Schedule 13D ownership disclosure

COGENT BIOSCIENCES INC

Security class unavailable · CUSIP: 19240Q201

Event date: 2022-06-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
15,230,473
Percent of class
19.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-072800
Form type
SC 13D/A
Filer
Cogent Biosciences, Inc.
CIK
CIK 1622229
Filed
Jun 21, 2022
Reporting period
Jun 16, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub